Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Clinical trial NCT05831995 · TERMINATED
Trial details
- NCT number
- NCT05831995
- Sponsor
- ABM Therapeutics Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2024-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.